TytoCare Ltd., an emerging Israel-based telehealth company has closed $11 million in Series B funding led by Cambia Health Solutions. Other participants in the round include OrbiMed Advisors, Walgreens, Fosum Pharma and LionBird. Founded in 2012, Tyto Care’s advanced cloud telehealth platform and handheld device allows for accurate remote diagnosis of various types of ailments. Click here to read more.
TytoCare Closes $11 Million of New Funding For the Upcoming Launch of its Telehealth Home Exam Platform
Nov 7, 2016Recent Press Releases
GBUAHN and Tyto Team Up for a Unique...
Nov 14, 2018 PR NEWSWIREThe Greater Buffalo United Accountable Healthcare Network (GBUAHN), a Medicaid health home specializing in care...
Read the articleTyto Care Receives CE Mark for Its On Demand,...
Nov 16, 2018 PR NEWSWIRETyto Care, an innovative telehealth company enabling on demand telehealth visits and comprehensive medical...
Read the articleTyto Care Positioned to Extend the Reach of...
Aug 16, 2018 PR NEWSWIRETyto Care Positioned to Extend the Reach of Physicians With Clinic-Quality Remote Exams for Canadian Consumers
Read the article
Sign Up to Learn More
Stay up to date by joining our mailing list.
Please submit your contact details below.
